These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6504948)

  • 1. Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens.
    Morgenstern R; Mende T; Gold R; Lemme P; Oelssner W
    Pharmacol Biochem Behav; 1984 Oct; 21(4):501-6. PubMed ID: 6504948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
    Morgenstern R; Fink H
    J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Locomotor activity and the nucleus accumbens].
    Morgenstern R; Gold R; Oelssner W
    Biomed Biochim Acta; 1983; 42(7-8):947-53. PubMed ID: 6651811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine--a serotonin antagonist?
    Fink H; Morgenstern R; Oelssner W
    Pharmacol Biochem Behav; 1984 Apr; 20(4):513-7. PubMed ID: 6728869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
    Fink H; Morgenstern R
    Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD-potentiated apomorphine hypermotility: a model for differentiating antipsychotic drugs.
    Morgenstern R; Fink H; Oelssner W
    Pharmacol Biochem Behav; 1983 Jan; 18(1):13-7. PubMed ID: 6681904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scopolamine-induced hypermotility in rats is mediated via a dopaminergic system.
    Fink H; Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):903-10. PubMed ID: 7282220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate induced-hypermotility response after bilateral injection into the nucleus accumbens of the rat. Possible mediation through dopaminergic mechanisms.
    Stephens RL; Uretsky NJ
    Neuropharmacology; 1986 Aug; 25(8):887-96. PubMed ID: 3022181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
    Boldry RC; Uretsky NJ
    Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior.
    Austin MC; Kalivas PW
    Brain Res; 1988 Feb; 441(1-2):209-14. PubMed ID: 3359231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GABAergic transmission in the subpallidal region on the hypermotility response to the administration of excitatory amino acids and picrotoxin into the nucleus accumbens.
    Shreve PE; Uretsky NJ
    Neuropharmacology; 1988 Dec; 27(12):1271-7. PubMed ID: 2907617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum.
    Austin MC; Kalivas PW
    Jpn J Pharmacol; 1989 Aug; 50(4):487-90. PubMed ID: 2779013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral function of GABA in the median raphe nucleus.
    Fink H; Morgenstern R
    Biomed Biochim Acta; 1986; 45(4):531-8. PubMed ID: 3707566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: possible dependence on dopaminergic mechanisms.
    Donzanti BA; Uretsky NJ
    Neuropharmacology; 1983 Aug; 22(8):971-81. PubMed ID: 6137783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility.
    Fink H; Oelssner W
    Eur J Pharmacol; 1981 Nov; 75(4):289-96. PubMed ID: 7318915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.
    Rupniak NM; Hall MD; Kelly E; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    J Neural Transm; 1985; 62(3-4):249-66. PubMed ID: 2863324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.